SELB

Selecta Biosciences Inc.

Price

return (12m)

p/e

-3.20

p/bv

1.92

DIVIDEND YIELD

0.00%

SELB price

Selecta Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SELB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SELB

Valuation

P/E

-3.20

Sector -3.50

Industry -3.50

P/BV

1.92

Sector 2.02

Industry 2.02

P/Revenue (PSR)

3.35

Sector 2.01

Industry 2.01

EV/EBITDA

Sector -214.99

Industry -214.99

EV/EBIT

Sector -47.59

Industry -47.59

P/EBITDA

-4.36

Sector -21.41

Industry -21.41

P/EBIT

-4.31

Sector -28.65

Industry -28.65

P/Total Assets

1.09

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

-0.23

Sector -1.81

Industry -1.81

BVPS

0.39

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

84.80%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-202.32%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-205.21%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.06

Sector 0.02

Industry 0.02

Profitability

ROE

-59.94%

Sector -56.04%

Industry -56.04%

ROA

-34.10%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

Sector -8.06

Industry -8.06

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.57

Sector 0.46

Industry 0.46

Liabilities/Assets

0.57

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

2.34%

Sector -

Industry -

5Y Earnings CAGR

7.08%

Sector -

Industry -

Fundamentals SELB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SELB Selecta Biosciences Inc.	$0.00	-	0.00%	-3.20	1.92	-59.94%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SELB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Selecta Biosciences

Selecta Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2016

Time since IPO - 10 years

45

Employees

Selecta Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $115.56 million, with shareholders equity totaling $60.33 million.

The company employs approximately 45 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Selecta Biosciences Inc. reported $34.53 million in revenue, generating net income of $-36.16 million.

Key financial metrics include a P/E ratio of -3.20, a price-to-book (P/B) ratio of 1.92, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SELB.

Market cap

$115.56 million

Net worth

$60.33 million

$60,329,000.00

Assets

$106.03 million

$106,034,000.00

Total Shares Outstanding

154.80 million

154,804,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

SELB

SELB revenue and profits

Financial Results SELB

DRAG THE FRAME TO SEE MORE DATA

SELB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Selecta Biosciences (SELB) today?

A cotação de Selecta Biosciences (SELB) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Selecta Biosciences (SELB) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Selecta Biosciences (SELB) e dados de ações do Ibovespa e mercados internacionais.

Quando Selecta Biosciences (SELB) paga dividendos?

Selecta Biosciences (SELB) não distribuiu dividendos no último ano.

Is Selecta Biosciences (SELB) a good investment?

Atualmente, Selecta Biosciences (SELB) está cotada a US$ 0.00, com um P/L de -3.20, representando um desvio de -44% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Selecta Biosciences (SELB) stock?

Investir em ações de Selecta Biosciences (SELB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Selecta Biosciences (SELB) yield today?

A rentabilidade de Selecta Biosciences (SELB) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Selecta Biosciences (SELB) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SELB

Selecta Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SELB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SELB WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Selecta Biosciences

Selecta Biosciences Inc.

United States

19 years

2016

45

PROFIT X PRICE SELB

Financial Results SELB

SELB cash flow

Asset, Revenue and Profit Growth - SELB

SELB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions